Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Atezolizumab in Large Cell Neuroendocrine Carcinoma of the Lung and the Value of miR21 and miR-375 as Biomarkers

NCT06049966 is registered in ClinicalTrials.gov with Oncology Center of Biochemical Education And Research as lead sponsor.

NCT NCT06049966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06049966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Atezolizumab in Large Cell Neuroendocrine Carcinoma of the Lung and the Value of miR21 and miR-375 as Biomarkers
Lead sponsor
Oncology Center of Biochemical Education And Research
Phase
Phase 1
Overall status
Completed
Start date
November 1, 2019
Completion date
September 1, 2025
Enrollment
22 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

large cell neuroendocrine carcinoma of the lung